[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper discusses EGFR mutations in lung cancer and investigates the effect of a particular mutation.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly addresses EGFR mutations and their relevance to lung cancer, establishing a clear disease mechanism."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper describes an enzyme activity assay to examine the impact of the mutation on kinase activity.",
        "judgment": "Yes",
        "reasoning": "Assessing enzyme activity is a relevant assay to determine the functional impact of mutations in kinase domains like EGFR.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The study compares kinase activity of the mutant EGFR to a wild-type control. Multiple experiments are performed.",
        "judgment": "Yes",
        "reasoning": "The presence of wild-type and mutant control experiments allows for comparison. The study also explicitly mentions multiple experiments."
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "The results are compared with previously reported pathogenic EGFR mutations.",
        "judgment": "Yes",
        "reasoning": "The study mentions comparison to previously known pathogenic variants, which serves as a form of variant control."
      },
      {
        "step_name": "Step 4a: Statistical Analyses",
        "extracted_paper_info": "The results show a statistically significant difference in kinase activity between the mutant and wild-type EGFR.",
        "judgment": "Yes",
        "reasoning": "The description of a statistically significant difference indicates statistical analysis has been performed."
      },
      {
        "step_name": "Step 4c: Correlate OddsPath",
        "extracted_paper_info": "The data shows a significantly increased kinase activity with a p-value of <0.001.",
        "judgment": "N/A",
        "reasoning": "While a p-value is provided, the precise OddsPath calculation isn't. From a p-value below 0.001 and significant increase in kinase activity, we can infer a supporting strength."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The EGFR L858R mutation demonstrates significantly increased kinase activity compared to wild-type EGFR, supported by statistical significance and comparison with other known pathogenic mutations. While a specific OddsPath isn't provided, this information suggests a supporting functional assessment for pathogenicity."
  }
]